NCT05432726 is a clinical trial of calculating CARG score in Solid Tumors ,Adults, sponsored by Assiut University.

Who is sponsoring NCT05432726?

NCT05432726 is sponsored by Assiut University.

What drugs are being tested in NCT05432726?

Interventions in NCT05432726: calculating CARG score.

What condition does NCT05432726 study?

NCT05432726 studies Solid Tumors ,Adults.

Is NCT05432726 still recruiting?

NCT05432726 is currently status unknown. Last updated 19 July 2022.

Last reviewed 2022-07-19 · How we verify

NCT05432726

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prediction of Chemotherapy Toxicity and Survival in Elderly Cancer Patients by CARG Score

Status unknown Last updated 19 July 2022

What this trial tests

trial testing calculating CARG score in Solid Tumors ,Adults in 63 participants. Status unknown.

Timeline

20 July 2022

Primary endpoint
1 July 2025

1 July 2025

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	63
Start date	20 July 2022
Primary completion	1 July 2025
Estimated completion	1 July 2025

Drugs / interventions tested

calculating CARG score

Conditions studied

Solid Tumors ,Adults — all drugs for Solid Tumors ,Adults →

Sponsor

Assiut University

Who can join

65 and older, any sex, with Solid Tumors ,Adults. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prediction of chemotherapy toxicity and survival in elderly (aged ≥65 years old) patients with advanced solid tumors receiving systemic chemotherapy by using CARG risk score.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05432726 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 19 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05432726.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing